tradingkey.logo

Lucid Diagnostics Inc <LUCD.OQ> expected to post a loss of 16 cents a share - Earnings Preview

ReutersMay 12, 2025 1:21 PM
  • Lucid Diagnostics Inc LUCD.OQ LUCD.O is expected to show a rise in quarterly revenue when it reports results on May 14 for the period ending March 31 2025

  • The New York City-based company is expected to report a 28.2% increase in revenue to $1.283 million from $1 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Lucid Diagnostics Inc is for a loss of 16 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Lucid Diagnostics Inc is $3.00​, above​ its last closing price of $1.13. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.19

-0.18

Beat

5.3

Sep. 30 2024

-0.22

-0.22

-0.25

Missed

-13.6

Jun. 30 2024

-0.22

-0.22

-0.23

Missed

-4.5​

Mar. 31 2024

-0.26

-0.27

-0.40

Missed

-49.3

​​Dec. 31 2023

-0.27

-0.26

-0.25

Beat

3

Sep. 30 2023

-0.27

-0.27

-0.34

Missed

-24.8​

Jun. 30 2023

-0.32

-0.32

-0.23

Beat

28.3

Mar. 31 2023

-0.34

-0.35

-0.40

Missed

-14.7

This summary was machine generated May 12 at 13:21 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI